CONVERT PHARMACEUTICALS

Convert Pharmaceuticals is a preclinical stage drug development company, that is building a proprietary drug pipeline exploiting tumor microenvironment specific factors for therapeutic benefit.Convert’s lead product is a hypoxia activated prodrug (HAP). Hypoxia constitutes a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. Convert Pharmaceuticals combines proprietary insights in the tumor microenvironment with expertise in drug and biomarker development to develop effective and well-tolerated HAPs.

#SimilarOrganizations #People #Financial #Website #More

CONVERT PHARMACEUTICALS

Social Links:

Linkedin

Industry:

Biotechnology Business Development Pharmaceutical

Founded:

2017-01-01

Address:

Liège, Liege, Belgium

Country:

Belgium

Website Url:

http://www.convertpharma.com

Total Employee:

1+

Status:

Active

Contact:

+32 2 880 67 30

Email Addresses:

[email protected]

Total Funding:

13.6 M EUR

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache

Similar Organizations

ability-pharmaceuticals-logo

Ability Pharmaceuticals

Ability Pharmaceuticals is a drug discovery and development company.

blade-therapeutics-logo

Blade Therapeutics

Blade Therapeutics is a discovery stage drug development company.

exo-therapeutics-logo

Exo Therapeutics

Exo Therapeutics is a small molecule drug discovery and development company.

magpie-pharmaceuticals-logo

Magpie Pharmaceuticals

Magpie Pharmaceuticals is a biotechnology company.

silicon-therapeutics-logo

Silicon Therapeutics

Silicon Therapeutics is a fully integrated drug design, research, and development company.

Current Advisors List

not_available_image

Arne Heyerick Vice President, Non-Clinical Development @ Convert Pharmaceuticals
Board_member
2017-01-01

Current Employees Featured

janwillem-naesens_image

Janwillem Naesens
Janwillem Naesens CEO @ Convert Pharmaceuticals
CEO
2017-01-01

not_available_image

Philippe Lambin
Philippe Lambin Chief Scientific Adviser & Co-Founder @ Convert Pharmaceuticals
Chief Scientific Adviser & Co-Founder

Founder

not_available_image

Philippe Lambin

Investors List

droia_image

Droia Ventures

Droia Ventures investment in Series A - Convert Pharmaceuticals

meusinvest_image

Meusinvest (Noshaq)

Meusinvest (Noshaq) investment in Series A - Convert Pharmaceuticals

eurostars_image

Eurostars

Eurostars investment in Series A - Convert Pharmaceuticals

spinventure_image

Spinventure

Spinventure investment in Series A - Convert Pharmaceuticals

walloon_image

Walloon

Walloon investment in Series A - Convert Pharmaceuticals

Official Site Inspections

http://www.convertpharma.com Semrush global rank: 5.23 M Semrush visits lastest month: 1.56 K

Host Informations
Whois Informations

Loading ...

More informations about "Convert Pharmaceuticals"

linkstock.net © 2022. All rights reserved